loader2
Login Open ICICI 3-in-1 Account
IPOLogoImag

JUPITER LIFE LINE HOSPITALS IPO

IPO Details

-
-
20 Shares
-
₹ 695 – 735
₹ Up to 869.08 Cr

Issue timeline

  • -
  • 13-Sep-2023
  • 14-Sep-2023
  • 15-Sep-2023
  • 18-Sep-2023

Subscription Status

Shareholder -
Qualified Institutional Buyers -
Non-Institutional Investor -
Retail Individual Investor -
Employee -
Total -

About Company

- Among the key multi-specialty tertiary and quaternary healthcare providers in the Mumbai Metropolitan Area (MMR) and western region of India(Source: CRISIL Report)
-They have been operating for over 15 years and currently operate three hospitals under the “Jupiter” brand in Thane, Pune and Indore
-Equipped their hospitals with over 30 specialties and has a total bed capacity of 1,194 hospital beds across three hospitals as of December 31, 2022 (Source: CRISIL Report)

Strengths & Risks

Strengths (3)

All-hub-no-spoke model with focus on quality patient care
Each of their three hospitals is a full-service hospital, operating on an ‘all-hub-no-spoke’ model where each hospital is independent, individually well-equipped with skilled healthcare professionals as well as advanced infrastructure(Source: Company DRHP)

Risks (2)

The industry is highly regulated. Any regulatory changes or violations of  rules and regulations may adversely affect business
Healthcare providers are subject to a wide variety of governmental, state and local environmental and occupational health and safety and other laws and regulations. If they fail to comply with the requirements for applicable quality standards, or if otherwise unable to obtain or renew such quality accreditations in the future, in a timely manner, or at all, their business and prospects may be adversely affected(Source: Company DRHP)

Financials

Industry Overview

- Health expenditure grew strong at 8.1% CAGR from Fiscal 2012 to Fiscal 2021 : Health personal expenditure increased from Rs.1,813 billion to Rs.3,661 billion from Fiscal 2012 to Fiscal 2021 supported by rise in government schemes, health spending by state, rise in income levels, rise in disease incidence. Health expenditure in terms of current prices rose at 14.4% CAGR between Fiscal 2012 and Fiscal 2021 (Source: Company DRHP)


- Indian healthcare delivery market poised for robust growth in the medium term :  Breaching pre-COVID level in Fiscal 2022, CRISIL MI&A Research estimates the Indian healthcare delivery industry to post healthy 10% to 12% compound annual growth rate between Fiscal 2022 and Fiscal 2027, driven by long term structural factors, strong fundamentals, increasing affordability and potential of the Ayushman Bharat scheme. (Source: Company DRHP)

*The financials mentioned above are sourced from DRHP/ RHP documents.